These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11141435)

  • 21. Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
    McMurray JJ; Young JB; Dunlap ME; Granger CB; Hainer J; Michelson EL; Earle S; Olofsson B; Ostergren J; Yusuf S; Swedberg K; Pfeffer MA;
    Am Heart J; 2006 May; 151(5):985-91. PubMed ID: 16644319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cross reactivity between ACE inhibitors and angiotensin receptor blockers].
    Rosenborg S
    Lakartidningen; 2010 Feb 17-23; 107(7):444. PubMed ID: 20384078
    [No Abstract]   [Full Text] [Related]  

  • 23. [Acute hepatitis induced by valsartan].
    Reñé JM; Buenestado J; Sesé E; Miñana JM
    Med Clin (Barc); 2001 Nov; 117(16):637-8. PubMed ID: 11714476
    [No Abstract]   [Full Text] [Related]  

  • 24. Lack of deleterious interaction between angiotensin receptor blockers and beta-blockers in the treatment of patients with heart failure.
    Hennekens CH; Kowalczykowski M; Hollar D
    J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):149-52. PubMed ID: 16891293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study.
    Schindler C; Mueller A; Bramlage P; Boecking W; Kirch W; Schweizer J
    Angiology; 2007 Dec-2008 Jan; 58(6):710-6. PubMed ID: 17928625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin receptor antagonists.
    Wong W; Howes L
    Aust Fam Physician; 2000 Jul; 29(7):653-5, 658. PubMed ID: 10914449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hepatoxicity by enalapril].
    Quílez C; Palazón JM; Chuliá T; Córdoba YC
    Gastroenterol Hepatol; 1999 Feb; 22(2):113-4. PubMed ID: 10193097
    [No Abstract]   [Full Text] [Related]  

  • 28. Warnings against candesartan in pregnancy are not implemented in physicians' practice.
    Borthen C; Oglaend B; Eggebøe T; Ellingsen CL; Schjøtt J
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):235. PubMed ID: 19615811
    [No Abstract]   [Full Text] [Related]  

  • 29. A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension.
    Lee JH; Yang DH; Hwang JY; Hur SH; Cha TJ; Kim KS; Kim MH; Chun KJ; Cha GS; Hong GR; Lee SG; Kim DS; Kim DI; Chae SC
    Clin Ther; 2016 Jun; 38(6):1485-1497. PubMed ID: 27161546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concomitant administration of candesartan cilexetil in patients on paclitaxel and carboplatin combination therapy increases risk of severe neutropenia
.
    Katsube Y; Hira D; Tsujimoto M; Koide H; Minegaki T; Ikeda Y; Morita SY; Nishiguchi K; Terada T
    Int J Clin Pharmacol Ther; 2018 Jul; 56(7):328-336. PubMed ID: 29792394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) study.
    Cuspidi C; Muiesan ML; Valagussa L; Salvetti M; Di Biagio C; Agabiti-Rosei E; Magnani B; Zanchetti A;
    J Hypertens; 2002 Nov; 20(11):2293-300. PubMed ID: 12409969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide.
    Malmqvist K; Kahan T; Dahl M
    Am J Hypertens; 2000 May; 13(5 Pt 1):504-11. PubMed ID: 10826401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valsartan-induced hepatotoxicity in a HBs-Ag-Positive patient.
    Kiykim A; Altintas E; Sezgin O; Sezer K; Tiftik N; Akbay E; Seyrek E; Konca K
    Am J Gastroenterol; 2003 Feb; 98(2):507. PubMed ID: 12591083
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of the combination of amlodipine and candesartan in hypertensive patients with coronary artery disease: a subanalysis of the HIJ-CREATE study.
    Koyanagi R; Hagiwara N; Yamaguchi J; Kawada-Watanabe E; Haruta S; Takagi A; Ogawa H;
    J Cardiol; 2013 Oct; 62(4):217-23. PubMed ID: 23778009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-II-receptor inhibitors in pregnancy.
    Hinsberger A; Wingen AM; Hoyer PF
    Lancet; 2001 May; 357(9268):1620. PubMed ID: 11386315
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of candesartan in acute stroke on cognitive function and quality of life: results from the Scandinavian Candesartan Acute Stroke Trial.
    Hornslien AG; Sandset EC; Bath PM; Wyller TB; Berge E;
    Stroke; 2013 Jul; 44(7):2022-4. PubMed ID: 23660849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ace inhibitors and angiotensin II receptor antagonists for therapy of chronic heart failure].
    Kuwabara Y; Komuro I
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):255-61. PubMed ID: 15768589
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased renal echogenicity in a preterm neonate. Kidneys with tubular dysplasia due to exposure to candesartan during pregnancy.
    Bald M; Holder M; Zieger M; Vochem M; Leichter HE
    Pediatr Nephrol; 2005 Nov; 20(11):1664-5, 1666-8. PubMed ID: 16082550
    [No Abstract]   [Full Text] [Related]  

  • 39. [Angiotensin receptor blockers in heart failure. CHARM Study].
    Kochsiek K
    Internist (Berl); 2004 Sep; 45(9):1063-7. PubMed ID: 15309315
    [No Abstract]   [Full Text] [Related]  

  • 40. Ductopenic hepatitis related to Enalapril.
    Macías FM; Campos FR; Salguero TP; Soria PT; Carrasco FG; Martín JM
    J Hepatol; 2003 Dec; 39(6):1091-2. PubMed ID: 14642633
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.